Although these results suggest that genetic variants linked to the FGF21 pathways are potentially involved in NAFLD pathogenesis, the evidence was based on cross-sectional studies, and the effect size of individual SNPs was limited. This evidence concerns the gene FGF21 and metabolic dysfunction-associated steatotic liver disease.